TMPRSS2 and prostate adenocarcinoma: The TMPRSS2:ERG gene fusion (T:E fusion) puts ERG under the androgen receptor–regulated (AR-regulated) expression of TMPRSS2, and it is an early truncal alteration found in about half of prostate adenocarcinoma (PCa) cases in men of European ancestry.